Use of etanercept in treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis.
A 30-year-old female with past medical history of autoimmune hepatitis was sent to our clinic for consultation and treatment of refractory pyoderma gangrenosum (PG) of bilateral lower extremities. At the time of presentation, she had failed treatment with prednisone, azathioprine and local wound care. Treatment options were limited by the patient's autoimmune hepatitis. This patient was treated with etanercept and a taper of oral prednisone, which resulted in a complete clinical cure of her PG. More studies are needed to evaluate the safety and efficacy of etanercept for PG in patients with liver disease.
Goldenberg
Gary
G
Department of Dermatology, Wake Forest University School of Medicine, Winston- Salem, NC 27157, USA.
Jorizzo
Joseph L
JL
D000328:Adult; D000068800:Etanercept; D005260:Female; D019693:Hepatitis, Autoimmune / Q000150:complications; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept